Related Business Topics
Latest Headlines
Reuters - Nov. 19, 2009, 5:59 AM
BOTHELL, WA, Nov 19 (MARKET WIRE) -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced presentations on the company's exon skipping therapy for Duchenne muscular dystrophy at the TREAT-NMD / NIH International Conference ...
Reuters - Nov. 18, 2009, 5:43 AM
BOTHELL, WA, Nov 18 (MARKET WIRE) -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that Patrick Iversen, Ph. D., Senior Vice President of Strategic Alliances, will present at the upcoming Transformational Medical ...
Times Online - Oct. 20, 2009, 8:10 AM
Mark Henderson, Science Editor A gene therapy for the most severe type of muscular dystrophy has achieved spectacular results in animal tests, opening a powerful new approach to treating people with the incurable wasting disease. The new drug, which ...
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
A
